The RepTrak Company

A reputation recovery is underway... The Financial Services industry has been on a challenging reputational path since the onset of the COVID-19 pandemic. As inflation surged and economic pressures mounted, the industry's reputation suffered the consequences.    Yet following 2023's bank crash, the industry's reputation is seeing a recovery in 2024. Read the latest report on our new RepTrak for Financial Services page to learn about stakeholders' growing confidence in financial institutions. Take control of your reputation today with RepTrak's industry solution for Financial Services companies. 💰 https://lnkd.in/ehSUrkB5

Pharma’s relationship with its stakeholders has dramatically evolved over the last few years. Previously, the industry relied on physicians to communicate with patients on their behalf, but COVID forced Pharma to engage with them in a new kind of direct engagement. Nowadays, it’s not just doctors making recommendations. People with conditions are becoming more involved in their healthcare options — and can be vocal advocates in recommending your products. At RepTrak, we go beyond traditional NPS surveys to provide a deeper understanding of stakeholders’ willingness to recommend, tracking sentiment over time. In H1 2024, Pharma’s Recommend Score rose to a strong 70.6, reflecting progress in stakeholder engagement With RepTrak, you get insight into the perceptions and expectations of your most important audiences, so you know what levers to pull for the business outcomes that are most important to your business. From patients to professionals, if you’re ready to mend relationships with your stakeholders, RapTrak for Pharma is here for you. Our industry solution can help you navigate the complex relationships you have with different stakeholder groups. Learn more at: https://lnkd.in/g_4ZEHHP

Reputation is not a static benchmark. It’s an ever-evolving asset that must be actively managed. The one constant industries can rely on is change. For companies aiming to succeed, developing a long-term reputation strategy is essential. Your corporate reputation is built on the perceptions of stakeholders. And if you’re not actively working to build it, someone else will do it for you. ➡️ Businesses that prioritize reputation management today are setting themselves up to thrive both now and in the future. Trust and credibility form the foundation of sustainable growth and companies that invest in these areas are better positioned to turn positive perceptions into concrete business outcomes. At RepTrak, we bridge the gap between perception and reality, transforming reputation into a measurable, actionable asset. Request a demo today: https://lnkd.in/g6pYZBJC

Perceptions of your industry don’t exist in isolation — they drive real actions. RepTrak’s Business Outcomes measure the actions stakeholders are willing to take when considering, supporting or engaging with your company. From recommending products to trusting you, Business Outcomes provide crucial insight into the behaviors of Pharma’s stakeholders (patients, healthcare professionals, investors, regulators, and more). These Scores reveal the “so what?” behind your Reputation Score showing the real-world impact on stakeholder engagement. By tracking these metrics, companies can: ✅ turn critics into advocates ✅ benchmark performance against competitors ✅ maintain strong relationships with key stakeholders Understanding Business Outcomes is essential, especially for Pharma companies that rely so much on building trust and credibility. If you’re ready to be a force in the industry, RepTrak for Pharma is here to help. Our tailored industry offerings help Pharma companies navigate critical reputation insights and pair them with actionable intelligence. Learn more at: https://lnkd.in/g_4ZEHHP

Generic data isn't enough to properly manage your corporate reputation. To thrive, businesses need sector-specific intelligence and expert guidance — and that’s exactly what RepTrak for Industry delivers. Across 30+ industries, RepTrak equips companies with actionable insights to build trust, manage risk, and drive measurable results. From regulatory compliance in Pharma, to customer engagement in Retail, our dedicated advisors and customized data are tailored to your unique challenges. Manage your entire reputation strategy in one platform, streamline decision-making, and stay ahead in an ever-changing market. Learn more about RepTrak for Industry: https://lnkd.in/e5AvTviJ

Managing corporate reputation effectively requires more than just data, it calls for expert guidance and actionable strategies. That’s where RepTrak's Advisory Insights comes in. Our innovative feature connects you directly with our seasoned advisory team, bringing a personalized touch to your reputation management. Whether it’s tailored advice on mitigating potential risks or managing a crisis, Advisory Insights gives you the expert guidance you need to maintain a strong reputation: ✅ Tailored stakeholder insights ✅ Actionable guidance ✅ Advisory library to access all your reports The best thing? You can manage all aspects of your reputation strategy from one central location, streamlining your processes and enhancing your ability to respond quickly to emerging challenges and opportunities. See why corporate communicators love this tool 🫶: https://lnkd.in/dPzQTEEK 

Pharma’s role in society is expanding 🌏 It’s no longer just about healing bodies, Pharma's role now extends to making broader contributions to general welfare. RepTrak’s Citizenship Driver measures a company’s efforts in making the world a better place — and stakeholders are paying attention. In H1 2024, Pharma’s Citizenship Score rose to 70.8, reflecting the industry's growing commitment to making a positive impact on society. Whether it's supporting good causes or promoting environmental sustainability, stakeholders now expect Pharma to help address other global challenges, not just pandemics. Consumers, in particular, are looking to Pharma to be a champion of holistic health. This convergence of sustainable wellness, holistic medicine, and preventative care puts further pressure on Pharma to act as a global corporate citizen, driving change in medicine and in the well-being of everyday life. By embracing these responsibilities, Pharma can foster greater trust and strengthen its reputation as a force for good in the world. If you’re ready to be a force in the industry, RepTrak for Pharma is here to help. Our tailored industry offerings help Pharma companies navigate critical reputation insights, and pair them with actionable intelligence. Learn more at: https://lnkd.in/g_4ZEHHP

Pharma’s recent reputational boost offers a chance for companies to build lasting trust — but how do you make it stick? 👥 Nathália Porto, Director of Advisory (Americas) at RepTrak, explains that it’s all about connecting with stakeholders: “Beyond expertise and compliance, Pharma companies need to build trust through proximity — positioning themselves as a trusted partner in stakeholders’ everyday health challenges and developing engagement efforts that actively drive consumer loyalty.” "A expertise e o respeito às regras do jogo no ambiente de negócios não são mais suficientes para alimentar a confiança do público nas empresas do setor Farmacêutico. As empresas devem trabalhar também sua proximidade às audiências, posicionando-se como parceiras ativas na jornada de melhoria da saúde das pessoas e engajando-as ativamente para garantir sua fidelidade como consumidores.” It’s about more than just meeting standards — it’s about becoming an essential part of everyday life. When Pharma companies work with RepTrak, they get paired with a team of industry-expert advisors. They’ll work you to interpret your reputation data, and work towards reputational growth. Discover more of our RepTrak for Pharma solutions: https://lnkd.in/g_4ZEHHP 

In 2024, Pharma’s Reputation Score climbed into the Strong range following a promising 🔼 0.8-point increase. This upward shift signals a recovery for Pharma companies post-pandemic. However, RepTrak data reveals that while stakeholders are more inclined to trust Pharma companies to do the right thing, they’re not ready to give them the benefit of the doubt following a crisis.  Our new quick-slides reviews the latest trends for Pharma's reputation with actionable strategies to sustain and enhance stakeholder perceptions. As part of our expansive industry suite, RepTrak’s solutions for Pharma deliver customized strategic insights that empower Pharma companies to meet evolving stakeholder expectations with long-term reputation strategies. See how RepTrak can help: https://lnkd.in/g_4ZEHHP